Private company

AngioGenex, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersNV
  • Incorporated inNV2
  • Business address425 Madison Avenue, Suite 902, New York, Ny 100172
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income34-$437.7K in 2018−0% since 2016
-$800.0K-$600.0K-$400.0K-$200.0K02016: -$438.0K-$438.0K20162017: -$646.2K-$646.2K2017+48%2018: -$437.7K-$437.7K2018−32%
Net income34-$435.4K in 2018−3% since 2016
-$800.0K-$600.0K-$400.0K-$200.0K02016: -$448.5K-$448.5K20162017: -$683.0K-$683.0K2017+52%2018: -$435.4K-$435.4K2018−36%
Fiscal year20152016201720182019
Research and development$49.4K3$291.3K4$30.7K4
Operating income-$438.0K3-$646.2K4-$437.7K4
Interest-$10.7K3-$36.4K4-$10.0K4
Net income-$448.5K3-$683.0K4-$435.4K4

Compare AngioGenex, Inc. with another company

Former names

  • ECLIC INC/NVMay 24, 1999 to Jan 5, 20062

Recent filings

  1. Feb 17, 20225
  2. Feb 16, 20225
  3. Feb 16, 20225
  4. Feb 15, 20225
  5. Dec 16, 20218-K AGGX 8-K 12/15/21

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4